文献速递临床试验与 GCP医学人工智能与信息学

机器学习与增强现实辅助的幻肢运动执行治疗慢性顽固性幻肢痛:单组临床试验

Phantom motor execution facilitated by machine learning and augmented reality as treatment for phantom limb pain: a single group, clinical trial in patients with chronic intractable phantom limb pain.
PubMed 文献 · Lancet · 2016-12-02

在瑞典和斯洛文尼亚的四家诊所纳入14例上肢截肢后慢性顽固性幻肢痛患者,接受12次基于机器学习、增强现实与虚拟现实及严肃游戏的幻肢运动执行训练。治疗后各项幻肢痛指标均出现统计学和临床显著改善,效果维持至末次治疗后6个月。

要点

  • 14例慢性顽固性幻肢痛患者接受12次幻肢运动执行训练后疼痛显著改善。
  • 加权疼痛分布下降47%,数字评定量表下降32%,疼痛评定量表指数下降51%。
  • 改善在末次治疗后6个月仍维持。

核心结论

  • 研究结果提示幻肢运动执行对幻肢痛可能具有治疗价值。
  • 借助机器学习、增强现实与虚拟现实及游戏促进幻肢运动执行是一种非侵入、非药物且具吸引力的治疗,目前未发现副作用。

研究设计与样本

  • 单组临床试验,在瑞典三家诊所和斯洛文尼亚一家诊所招募上肢截肢且已知慢性顽固性幻肢痛的患者,共14例入组。
  • 患者接受12次幻肢运动执行训练,使用机器学习、增强现实与虚拟现实及严肃游戏。
  • 在每次训练前及末次训练后1、3、6个月随访时评估幻肢痛强度、频率、持续时间、质量及侵扰程度,并监测药物与假肢变化。
  • 结果采用描述性统计和非参数检验分析,试验注册号NCT02281539。

主要发现

  • 2014年9月15日至2015年4月10日入组14例常规治疗失败的顽固性慢性幻肢痛患者。
  • 12次训练后,加权疼痛分布从治疗前至末次治疗下降47%(SD 39;绝对平均变化1.0[0.8];p=0.001)。
  • 数字评定量表下降32%(SD 38;绝对平均变化1.6[1.8];p=0.007),疼痛评定量表指数下降51%(SD 33;绝对平均变化9.6[8.1];p=0.0001)。
  • 幻肢痛对日常生活活动和睡眠侵扰的数字评定量表评分分别下降43%(SD 37;绝对平均变化2.4[2.3];p=0.004)和61%(SD 39;绝对平均变化2.3[1.8];p=0.001)。
  • 4例用药患者中2例减少摄入量:加巴喷丁减少81%(绝对减少1300 mg),普瑞巴林减少33%(绝对减少75 mg);改善在末次治疗后6个月仍维持。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Phantom limb pain is a debilitating condition for which no effective treatment has been found. We hypothesised that re-engagement of central and peripheral circuitry involved in motor execution could reduce phantom limb pain via competitive plasticity and reversal of cortical reorganisation. METHODS: Patients with upper limb amputation and known chronic intractable phantom limb pain were recruited at three clinics in Sweden and one in Slovenia. Patients received 12 sessions of phantom motor execution using machine learning, augmented and virtual reality, and serious gaming. Changes in intensity, frequency, duration, quality, and intrusion of phantom limb pain were assessed by the use of the numeric rating scale, the pain rating index, the weighted pain distribution scale, and a study-specific frequency scale before each session and at follow-up interviews 1, 3, and 6 months after the last session. Changes in medication and prostheses were also monitored. Results are reported using descriptive statistics and analysed by non-parametric tests. The trial is registered at ClinicalTrials.gov, number NCT02281539. FINDINGS: Between Sept 15, 2014, and April 10, 2015, 14 patients with intractable chronic phantom limb pain, for whom conventional treatments failed, were enrolled. After 12 sessions, patients showed statistically and clinically significant improvements in all metrics of phantom limb pain. Phantom limb pain decreased from pre-treatment to the last treatment session by 47% (SD 39; absolute mean change 1·0 [0·8]; p=0·001) for weighted pain distribution, 32% (38; absolute mean change 1·6 [1·8]; p=0·007) for the numeric rating scale, and 51% (33; absolute mean change 9·6 [8·1]; p=0·0001) for the pain rating index. The numeric rating scale score for intrusion of phantom limb pain in activities of daily living and sleep was reduced by 43% (SD 37; absolute mean change 2·4 [2·3]; p=0·004) and 61% (39; absolute mean change 2·3 [1·8]; p=0·001), respectively. Two of four patients who were on medication reduced their intake by 81% (absolute reduction 1300 mg, gabapentin) and 33% (absolute reduction 75 mg, pregabalin). Improvements remained 6 months after the last treatment. INTERPRETATION: Our findings suggest potential value in motor execution of the phantom limb as a treatment for phantom limb pain. Promotion of phantom motor execution aided by machine learning, augmented and virtual reality, and gaming is a non-invasive, non-pharmacological, and engaging treatment with no identified side-effects at present. FUNDING: Promobilia Foundation, VINNOVA, Jimmy Dahlstens Fond, PicoSolve, and Innovationskontor Väst.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Ortiz-Catalan M, Guðmundsdóttir RA, Kristoffersen MB, et al. Phantom motor execution facilitated by machine learning and augmented reality as treatment for phantom limb pain: a single group, clinical trial in patients with chronic intractable phantom limb pain. Lancet. 2016. PMID: 27916234. doi:10.1016/S0140-6736(16)31598-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。